Eton Pharmaceuticals (ETON) Enterprise Value (2019 - 2025)
Eton Pharmaceuticals (ETON) has disclosed Enterprise Value for 7 consecutive years, with -$25.9 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 73.69% to -$25.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$25.9 million through Dec 2025, down 73.69% year-over-year, with the annual reading at -$25.9 million for FY2025, 73.69% down from the prior year.
- Enterprise Value hit -$25.9 million in Q4 2025 for Eton Pharmaceuticals, up from -$37.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$13.4 million in Q3 2022 to a low of -$37.1 million in Q3 2025.
- Historically, Enterprise Value has averaged -$20.3 million across 5 years, with a median of -$19.0 million in 2024.
- Biggest five-year swings in Enterprise Value: tumbled 209.72% in 2021 and later skyrocketed 41.09% in 2022.
- Year by year, Enterprise Value stood at -$14.4 million in 2021, then fell by 13.18% to -$16.3 million in 2022, then plummeted by 31.17% to -$21.4 million in 2023, then soared by 30.17% to -$14.9 million in 2024, then plummeted by 73.69% to -$25.9 million in 2025.
- Business Quant data shows Enterprise Value for ETON at -$25.9 million in Q4 2025, -$37.1 million in Q3 2025, and -$25.4 million in Q2 2025.